Seattle Genetics, a biotechnology company that develops antibody-based cancer treatments, announced Wednesday that it will acquire Cascadian Therapeutics and the… Read More
A study conducted by Fred Hutchinson Cancer Research Center, with contributions from researchers across North America, has found stark differences… Read More
Scientists at Seattle’s Fred Hutchinson Cancer Research Center have figured out how to use venom from the Israeli deathstalker scorpion to “light up”… Read More
Seattle-based Juno Therapeutics has acquired RedoxTherapies for $10 million, to secure exclusive rights to a molecule that may provide a new… Read More
Commercial partners can help non-profits, like the Fred Hutchinson Cancer Research Center, bring life-saving treatments to patients faster. That’s why… Read More
A quarter-century after her discovery of the BRCA1 breast cancer gene, University of Washington geneticist Mary-Claire King has received the nation’s… Read More